Jade Biosciences, Inc. ( JBIO) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 2:15 PM EST ...
Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to ...
Summit Therapeutics Inc. (SMMT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Summit Therapeutics Inc. ( SMMT) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 12:45 PM EST ...
Bristol Myers Squibb today announced positive topline results from SCOUT-HCM, a Phase 3 trial evaluating Camzyos (mavacamten) ...
Ahead of the Union Budget 2026, education experts have called for a shift towards improving quality, infrastructure, and ...
An international group of researchers led by Pompeu Fabra University has discovered the nanomachine that controls ...
Metabolism, far from being just a housekeeping function, underlies all changes in cell size and function ...
Scientists have uncovered a new way embryonic cells divide when conventional mechanisms fail. Cell division underpins all ...
To stay healthy, our cells rely on a self-cleaning mechanism that removes defective or unnecessary components. This process, ...
In silico antibody accessibility analysis indicates that ectodomain epitopes are transiently exposed, while MPER epitopes are virtually always occluded in the pre-fusion trimer.
Learning doesn’t always mean flipping through heavy textbooks or sitting in a long lecture. Sometimes, it just takes ...
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results